Navelbine

Active Ingredient(s): Vinorelbine
FDA Approved: * December 23, 1994
Pharm Company: * PIERRE FABRE
Category: Cancer

Vinorelbine (NVB), sold under the brand name Navelbine among others, is a chemotherapy medication used to treat a number of types of cancer.[3] This includes breast cancer and non-small cell lung cancer.[3] It is given by injection into a vein or by mouth.[3][1] Common side effects include bone marrow suppression, pain at the site of injection, vomiting, feeling tired, numbness, and diarrhea.[3] Other serious side... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Navelbine 10 mg/ml Intravenous Injection
NDC: 64370-532
Labeler:
Pierre Fabre Medicament